GSK To Buy US Biotech Biz IDRx For Up To $1.15B
By Najiyya Budaly ( January 13, 2025, 10:44 AM GMT) -- British pharmaceutical giant GSK PLC said Monday that it will buy Boston-based IDRx Inc. for up to $1.15 billion as it seeks to expand its portfolio of treatments for gastrointestinal cancers....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.